In FAD patients harboring APP mutations near the BACE1 cleavage site, APP is likely hydrolyzed by the Aβ-producing pathway [20,21,22], resulting in excessive accumulation of insoluble Aβ and the eventual development of AD. This evidence concerns the gene APP and Alzheimer disease.